Richard L Md Lindstrom Ocular Therapeutix, Inc (OCUL) insider trading activity

Richard L Md Lindstrom is Director of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 143,145 shares of OCUL, which is worth approximately $1.38 Million. The most recent transaction as insider was on Jun 11, 2025, when has been sold 14,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 143K

12.02% 3M change

5.02% 12M change

Total Value Held $1.38 Million

RICHARD L MD LINDSTROM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2025	BUY Grant, award, or other acquisition	-	14,000 Added 8.91%	143,145 Common Stock
May 08 2025	BUY Open market or private purchase	$69,600 $6.96 p/Share	10,000 Added 5.47%	172,704 Common Stock
Jul 24 2024	BUY Grant, award, or other acquisition	-	12,000 Added 6.87%	162,704 Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	$266,657 $8.8 p/Share	30,302 Added 16.74%	150,704 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	12,000 Added 9.06%	120,402 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	8,933 Added 7.61%	108,402 Common Stock
May 12 2022	BUY Exercise of conversion of derivative security	$11,552 $1.22 p/Share	9,469 Added 8.69%	99,469 Common Stock
May 20 2021	SELL Open market or private sale	$143,000 $14.3 p/Share	10,000 Reduced 10.0%	90,000 Common Stock

Also insider at

HROW

HARROW HEALTH, INC. Healthcare

Director

LNSR

LENSAR, Inc. Healthcare

RLM